4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-430504
Chief Executive Officer sold 2,210 shares at $29.16 ($64,448)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-10-21 | Sale 10b5-1 | −2,210 | $29.16 | $64,448 | 450,035 | D: show line 1 in the form |
| Open-market sales · 2,210 sh · avg $29.16 · $64,448 | |||||||
Loading xslF345X06/ownership.xml…